Stocktoria
NEXGEL, INC. NXGL
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-12-22
NEXGEL, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $11.4M | $8.7M | $4.1M | $2.0M | $1.6M |
| Gross profit | $4.5M | $2.7M | $374,000 | $256,000 | $8,000 |
| R&D expense | $2,000 | $78,000 | $103,000 | $367,000 | $31,000 |
| SG&A expense | $7.9M | $6.2M | $3.7M | $3.2M | $2.5M |
| Operating income | -$3.4M | -$3.6M | -$3.5M | -$3.3M | -$2.6M |
| Interest expense | — | — | $15,000 | $1.3M | — |
| Income tax | — | — | — | $0 | $0 |
| Net income | -$3.0M | -$3.3M | -$3.2M | -$4.7M | -$4.3M |
| EPS (diluted) | $-0.38 | $-0.50 | $-0.56 | $-0.85 | $-1.45 |
| Operating cash flow | -$1.3M | -$3.9M | -$3.2M | -$3.0M | -$2.8M |
| Free cash flow | -$1.4M | -$4.3M | -$3.9M | -$3.1M | -$3.0M |
| Cash & equivalents | — | $1.8M | $2.7M | — | $13.3M |
| Inventory | $2.1M | $1.8M | $1.3M | $502,000 | $291,000 |
| Total assets | $10.5M | $11.0M | $10.0M | $10.4M | $17.0M |
| Total liabilities | $5.6M | $4.9M | $4.8M | $2.7M | $4.9M |
| Shareholders' equity | $4.9M | $6.1M | $5.2M | $7.6M | $12.1M |
Source: SEC EDGAR filings · CIK 0001468929 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.